Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials.
成人和青少年慢性特發性蕁麻疹患者中利格利珠單抗的療效和安全性:兩項3期隨機對照試驗結果。
Lancet 2024-04-05
Atopic dermatitis: a comprehensive updated review of this intriguing disease with futuristic insights.
特應性皮膚炎:這種引人入勝的疾病的全面更新回顧與未來展望。
Inflammopharmacology 2025-02-07